And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to make sure that we are dealing with this problem up front because the problem that we have seen over the last 5 or 6 years where coverage has shrunk some as the cost of drugs has gotten higher and higher that is a dangerous warning sign for what is to come if there isn't some kind of approach that looks to the future of these drugs, as Congressman Burgess said million dollar drugs for various therapies start coming to market. We need a more rational way to do this.
Michael Burgess: “And this is why we are very eager, particularly as we move toward much more expensive biotech drugs in the future to…”
Editor's note · Context
Burgess emphasizes the need for proactive measures against rising drug costs.
Share
More from Michael Burgess
For the purpose of debate only, I yield the customary 30 minutes to the gentleman from Massachusetts (Mr. McGovern), pending which I yield myself such time as I may consume. During consideration of this resolution, all time yielded is for…
I never expected that CMMI was actually going to deliver the cost savings that was promised.
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I will simply underscore the fact that entry- level chemists at the EPA are hired at much higher than the GSA rate. These are not highly sought-after scientists. These are entry-level applicants, and there is no shortage of applicants for…





